Ignite Creation Date:
2025-12-24 @ 11:52 PM
Ignite Modification Date:
2026-02-12 @ 7:47 PM
Study NCT ID:
NCT01659151
Status:
COMPLETED
Last Update Posted:
2025-11-04
First Post:
2012-08-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Vemurafenib With Lymphodepletion Plus Adoptive Cell Transfer & High Dose IL-2 Metastatic Melanoma
Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-08-03
Start Date Type:
ACTUAL
Primary Completion Date:
2021-10-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-08-19
Completion Date Type:
ACTUAL
First Submit Date:
2012-08-03
First Submit QC Date:
None
Study First Post Date:
2012-08-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-12-07
Results First Submit QC Date:
None
Results First Post Date:
2022-02-03
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-30
Last Update Post Date:
2025-11-04
Last Update Post Date Type:
ESTIMATED